Clinical Significance of Plasma Endothelin-1 Level After Bosentan Administration in Pulmonary Arterial Hypertension

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2009.01.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bosentan and Improved Pulmonary Endothelial Function in Pulmonary Arterial Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection

PLoS ONE
Multidisciplinary
2016English

Pharmacokinetic and Clinical Profile of a Novel Formulation of Bosentan in Children With Pulmonary Arterial Hypertension: The FUTURE-1 Study

British Journal of Clinical Pharmacology
Pharmacology
2009English

Effects of Bosentan on Peripheral Endothelial Function in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2016English

Plasma sFlt-1 Fluctuations in Response to Pulmonary Arterial Hypertension Treatment

Cardiovascular Pharmacology: Open Access
2017English

The Prognostic Significance of Pulmonary Arterial Capacitance in Pulmonary Arterial Hypertension: Single-Center Experience

Pulmonary Circulation
PulmonaryRespiratory Medicine
2016English

Combining Bosentan and Sildenafil in Pulmonary Arterial Hypertension Patients Failing Monotherapy: Real-World Insights

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2002English

The New Endothelin Receptor Antagonist Macitentan: Prospects for Therapy of Pulmonary Arterial Hypertension

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy